nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An anti-cell migration compound that binds to hnRNP U and suppresses nuclear deformation
|
Toma, Tsugumasa |
|
|
156 |
C |
p. |
artikel |
2 |
Antimicrobial activity and applications in PMMA of a novel benzpyrole derivant/iodocuprate hybrid (TMBI)2(Cu2I4)
|
Ruan, Chenglu |
|
|
156 |
C |
p. |
artikel |
3 |
A perspective on the application of macrocyclic design strategies in antitumor drugs
|
Li, Yan-Hong |
|
|
156 |
C |
p. |
artikel |
4 |
A promising future for breast cancer therapy with hydroxamic acid-based histone deacetylase inhibitors
|
Das, Tanima |
|
|
156 |
C |
p. |
artikel |
5 |
AT1, a small molecular degrader of BRD4 based on proteolysis targeting chimera technology alleviates renal fibrosis and inflammation in diabetic nephropathy
|
Yang, Meng |
|
|
156 |
C |
p. |
artikel |
6 |
Bioorganic compounds in quorum sensing disruption: strategies, Mechanisms, and future prospects
|
Subramani, Tarunkarthick |
|
|
156 |
C |
p. |
artikel |
7 |
Calliloboapins A-L, diterpenoids from the branches and leaves of Callicarpa loboapiculata and their biological activities
|
Liu, Ting |
|
|
156 |
C |
p. |
artikel |
8 |
Carbonic anhydrase inhibitors: Structural insights and therapeutic potential
|
Singh, Priti |
|
|
156 |
C |
p. |
artikel |
9 |
Corrigendum to “Repurposing eugenol and cinnamaldehyde as potent antimicrobial agents: A comprehensive in-vitro and in-silico study” [Bioorg. Chem. 156 (2025) 108199]
|
Qureshi, Kamal A. |
|
|
156 |
C |
p. |
artikel |
10 |
Corrigendum to “Surface display and characterization of recombinant α-l-Rhamnosidase from Emiliania huxleyi on Pichia pastoris” [Bioorg. Chem. 155 (2025) 108121]
|
Xie, Xi |
|
|
156 |
C |
p. |
artikel |
11 |
Corrigendum to “Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer’s disease” [Bioorg. Chem. 147 (2024) 107373]
|
Das, Bhanuranjan |
|
|
156 |
C |
p. |
artikel |
12 |
Corrigendum to “Synthesis of novel 1,2,3-triazole-tethered N-acyl hydrazones as a new class of carbonic anhydrase II inhibitors: In vitro and in silico potentials” [Bioorg. Chem. 153 (2024) 107822]
|
Fatima, Noor |
|
|
156 |
C |
p. |
artikel |
13 |
COX-2-targeted fluorescent probe for ClO- monitoring in precise cancer detection
|
Jin, Lingyu |
|
|
156 |
C |
p. |
artikel |
14 |
Current development in sulfonamide derivatives to enable CNS-drug discovery
|
Blicharz-Futera, Klaudia |
|
|
156 |
C |
p. |
artikel |
15 |
Dehydroepiandrosterone ameliorates primary dysmenorrhea by suppressing the SP1/Hsp90ab1/COX-2 signaling pathway
|
Wang, Daojuan |
|
|
156 |
C |
p. |
artikel |
16 |
20-Deoxyingenol ester and ether derivatives: Synthesis, properties and cytotoxicity
|
Liu, Zijian |
|
|
156 |
C |
p. |
artikel |
17 |
Design and synthesis of new 1,2,3-triazole derivatives as VEGFR-2/telomerase downregulatory candidates endowed with apoptotic potential for cancer treatment
|
Al-Karmalawy, Ahmed A. |
|
|
156 |
C |
p. |
artikel |
18 |
Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors
|
Morcoss, Martha M. |
|
|
156 |
C |
p. |
artikel |
19 |
Design, Synthesis, Biocompatibility, molecular docking and molecular dynamics studies of novel Benzo[b]thiophene-2-carbaldehyde derivatives targeting human IgM Fc Domains
|
Rajimon, K.J. |
|
|
156 |
C |
p. |
artikel |
20 |
Design, synthesis, crystal structure, fungicidal activity, and mechanism of action of novel thiazole-based hydrazide derivatives containing the 4-aminoquinazoline moiety
|
Yi, Mingyan |
|
|
156 |
C |
p. |
artikel |
21 |
Design, synthesis, in-vitro and in-silico studies of novel N-heterocycle based hydrazones as α-glucosidase inhibitors
|
Farooqi, Rehmatullah |
|
|
156 |
C |
p. |
artikel |
22 |
Detecting mitochondrial hypochlorous acid and viscosity in atherosclerosis models via NIR fluorescent probes
|
Cheng, Quanli |
|
|
156 |
C |
p. |
artikel |
23 |
Development and First-in-Human evaluation of a Site-Specific [18F]-Labeled PD-L1 nanobody PET radiotracer for noninvasive imaging in NSCLC
|
Ma, Xiaopan |
|
|
156 |
C |
p. |
artikel |
24 |
Development of novel epoxyketone macrocyclic peptidyl proteasome inhibitors through OPA-mediated one-step cyclization of unprotected peptides
|
Zeng, Gongruixue |
|
|
156 |
C |
p. |
artikel |
25 |
Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization
|
Shaheen, Mennatallah A. |
|
|
156 |
C |
p. |
artikel |
26 |
Discovery of 1,2,4-benzotriazine derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors
|
Mao, Jie |
|
|
156 |
C |
p. |
artikel |
27 |
Discovery of highly oxygenated cytochalasans with antiproliferative activity from an endophytic fungus Boeremia exigua
|
Tian, Chun |
|
|
156 |
C |
p. |
artikel |
28 |
Discovery of novel benzo[b][1,4]oxazine derivatives as ferroptosis inhibitors
|
Wan, Bi-Wen |
|
|
156 |
C |
p. |
artikel |
29 |
Discovery of quorum sensing inhibitors against Pseudomonas aeruginosa from Aspergillus sp. NB12
|
Lan, Xueqi |
|
|
156 |
C |
p. |
artikel |
30 |
Dual-targeting inhibitors involving tubulin for the treatment of cancer
|
Yakkala, Prasanna Anjaneyulu |
|
|
156 |
C |
p. |
artikel |
31 |
Editorial Board
|
|
|
|
156 |
C |
p. |
artikel |
32 |
Exploration of anti-inflammatory activity of pyrazolo[3,4-d]pyrimidine/1,2,4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: Design, synthesis, in silico and in vivo studies
|
Aziz, Marwa A. |
|
|
156 |
C |
p. |
artikel |
33 |
Exploring daidzein dimethyl ether from Albizzia lebbeck as a novel quorum sensing inhibitor against Pseudomonas aeruginosa: Insights from in vitro and in vivo studies
|
Zhao, Yiming |
|
|
156 |
C |
p. |
artikel |
34 |
Exploring i-Motif DNA binding with benzothiazolino Coumarins: Synthesis, Screening, and spectroscopic insights
|
Bag, Sagar |
|
|
156 |
C |
p. |
artikel |
35 |
Fragment-Based Drug Discovery: Small Fragments, Big Impact − Success Stories of Approved Oncology Therapeutics
|
Khedkar, Nilesh Raghunath |
|
|
156 |
C |
p. |
artikel |
36 |
Function and inhibition of the DNA repair enzyme SNM1A
|
Berney, Mark |
|
|
156 |
C |
p. |
artikel |
37 |
Halogenated meroterpenoids with antifungal activities from the Deep-Sea-Derived fungus Acremonium sclerotigenum guided by the genomic and OSMAC strategy
|
Huo, Ruiyun |
|
|
156 |
C |
p. |
artikel |
38 |
Identification of a 7H-pyrrolo[2,3-d]pyrimidin derivatives as selective type II c-Met/Axl inhibitors with potent antitumor efficacy
|
Qin, Songhui |
|
|
156 |
C |
p. |
artikel |
39 |
Identification of a novel Src inhibitor K882 derived from quinazoline-based stilbenes with anti-NSCLC effect
|
Ma, Xiuwei |
|
|
156 |
C |
p. |
artikel |
40 |
Imidazole-1,2,4-oxadiazole-piperazine hybrids as potent anticancer agents: Synthesis, biological evaluation and molecular docking
|
Nagineni, Devendra |
|
|
156 |
C |
p. |
artikel |
41 |
Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: Consequences for medical applications
|
Reuning, Ute |
|
|
156 |
C |
p. |
artikel |
42 |
Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy
|
Lengerli, Deniz |
|
|
156 |
C |
p. |
artikel |
43 |
Issue TOC
|
|
|
|
156 |
C |
p. |
artikel |
44 |
Kinases and their derived inhibitors from natural products
|
Chiwoneso, Takudzwa Chipeperengo |
|
|
156 |
C |
p. |
artikel |
45 |
MCL-1 as a potent target for cancer: Recent advancements, structural insights and SAR studies
|
Sharma, Vishakha |
|
|
156 |
C |
p. |
artikel |
46 |
Molecular Design, Synthesis and Anti-cancer Activity of Novel Pyrazolo[3,4-b]pyridine-based Glycohybrid Molecules
|
Verma, Neetu |
|
|
156 |
C |
p. |
artikel |
47 |
New 2-indolinone-indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors
|
Camcı-Eren, Merve |
|
|
156 |
C |
p. |
artikel |
48 |
New indolin-2-ones, possessing sunitinib scaffold as HDAC inhibitors and anti-cancer agents with potential VEGFR inhibition activity; design, synthesis and biological evaluation
|
Yousefian, Mozhdeh |
|
|
156 |
C |
p. |
artikel |
49 |
New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers
|
Ismail, Magda M.F. |
|
|
156 |
C |
p. |
artikel |
50 |
New N-Alkylketonetetrahydroisoquinoline derivatives exhibits antitumor effect by HA-CD44 interaction inhibition in MDA-MB-231 breast cancer
|
Chayah, Meriem |
|
|
156 |
C |
p. |
artikel |
51 |
New series of fluoroquinolone derivatives as potential anticancer Agents: Design, Synthesis, in vitro biological Evaluation, and Topoisomerase II Inhibition
|
Adly, Mina E. |
|
|
156 |
C |
p. |
artikel |
52 |
New triterpenoid saponins isolated from the leaves of Astragalus membranaceus (Fisch.) Bge. and their neuroprotective effects
|
Xu, Wenxiang |
|
|
156 |
C |
p. |
artikel |
53 |
N-formylkynurenine but not kynurenine enters a nucleophile-scavenging branch of the immune-regulatory kynurenine pathway
|
Wang, Yongxin |
|
|
156 |
C |
p. |
artikel |
54 |
N-Heterocyclic functionalized chalcone derivatives as anti-inflammatory agents for atopic dermatitis treatment by inhibiting JAK1/STAT3 signaling pathway
|
Huang, Zhengxiao |
|
|
156 |
C |
p. |
artikel |
55 |
Novel Pyrrolidine-bearing quinoxaline inhibitors of DNA Gyrase, RNA polymerase and spike glycoprotein
|
Ebrahim, Maha A. |
|
|
156 |
C |
p. |
artikel |
56 |
Novel steroidal oximes as antiproliferative agents: Design, synthesis and biological activity evaluation
|
Gomes, Ana R. |
|
|
156 |
C |
p. |
artikel |
57 |
Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics
|
Ghannam, Iman A.Y. |
|
|
156 |
C |
p. |
artikel |
58 |
Polydatin, a derivative of resveratrol, ameliorates busulfan-induced oligozoospermia in mice by inhibiting NF-κB pathway activation and suppressing ferroptosis
|
Wang, Chengniu |
|
|
156 |
C |
p. |
artikel |
59 |
Rapid screening of acetylcholinesterase inhibitors in Qi-Fu-Yin using magnetic metal–organic frameworks immobilized with acetylcholinesterase
|
Li, Hengyu |
|
|
156 |
C |
p. |
artikel |
60 |
Repurposing eugenol and cinnamaldehyde as potent antimicrobial agents: A comprehensive in-vitro and in-silico study
|
Qureshi, Kamal A. |
|
|
156 |
C |
p. |
artikel |
61 |
Role of PARP-1 structural and functional features in PARP-1 inhibitors development
|
Merkuryev, Alexander Vladimirovich |
|
|
156 |
C |
p. |
artikel |
62 |
Specific Rosetta-based protein-peptide prediction protocol allows the design of novel cholinesterase inhibitor peptides
|
Sanchis, Ivan |
|
|
156 |
C |
p. |
artikel |
63 |
Spiropyran-based triphenylamine AlEgens: pH-responsive and light-activated mitochondria-targeted fluorescence imaging
|
Liang, Xi |
|
|
156 |
C |
p. |
artikel |
64 |
SVCT2-targeted PET imaging agent for the evaluation of LN metastasis of thyroid cancer
|
Peng, Lei |
|
|
156 |
C |
p. |
artikel |
65 |
Synthesis and antitumor activity of a novel class of covalent inhibitors of EGFR with 2-indolone backbone
|
Tan, Huayuan |
|
|
156 |
C |
p. |
artikel |
66 |
Synthesis and biological evaluation of new dual APN/NEP inhibitors as potent analgesics
|
Zhang, Naining |
|
|
156 |
C |
p. |
artikel |
67 |
Synthesis of new functionalized bioactive S-substituted indolyl-triazoles as cytotoxic and apoptotic agents through multi-targeted kinase inhibition
|
Boraei, Ahmed T.A. |
|
|
156 |
C |
p. |
artikel |
68 |
Targeting Wnt signaling pathway with small-molecule therapeutics for treating osteoporosis
|
Ahamad, Shakir |
|
|
156 |
C |
p. |
artikel |
69 |
The discovery of a new uncompetitive inhibitor of nucleoside hydrolase from Leishmania donovani
|
Alves, Marina A. |
|
|
156 |
C |
p. |
artikel |
70 |
The insight into the intermolecular interactions between protamine and insulin lispro
|
Wang, Guangqi |
|
|
156 |
C |
p. |
artikel |
71 |
The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia
|
Qian, Zhuo |
|
|
156 |
C |
p. |
artikel |
72 |
Unraveling the synthetic strategy, structure activity relationship of azetidinones: Insights into their multidrug and toxin extrusion protein (MATE transporter) inhibition facilitating drug development against MDR
|
Mal, Suvadeep |
|
|
156 |
C |
p. |
artikel |
73 |
Unveiling the anticancer potential and toxicity of Ganoderma applanatum wild mushroom derived bioactive compounds: An in vitro, in vivo and in silico evaluation
|
Rijia, Akbar |
|
|
156 |
C |
p. |
artikel |